Aditya Rajagopal

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Luxtera, Inc. engages in the development and delivery of silicon complementary metal-oxide-semiconductor (CMOS) photonics. Its CMOS technology provides bandwidth for applications ranging from local area network to chip-to-chip interconnect. The company was founded by Alex Dickinson, Axel Scherer, Eli Yablonovitch and Lawrence Cary Gunn III in 2001 and is headquartered in Carlsbad, CA.

Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT.

Benvenue Medical, Inc. engages int the provision and development of invasive systems for spine repair. It offers Kiva an implant solution for vertebral augmentation and a departure from balloon kyphoplasty, Blazer-C a vertebral augmentation system that utilizes a unique cannulated curved wire offering mechanical channel creation, and Luna a interbody implant that is delivered through a minimally-invasive cannula to the disc space and expands in-situ. The company was founded by Laurent B. Schaller in 2004 and is headquartered in Santa Clara, CA.

NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Rochester Institute of Technology is a privately endowed, coeducational university with ten colleges emphasizing career education and experiential learning. It was founded in 1829 and is headquartered in Rochester, NY.

Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA.

Helixis, Inc. develops a molecular diagnostic testing platform for use in diverse physical locations. The company was founded in 2007 by David Baltimore, Alex Dickinson, Matthew Johnston, George Maltezos & Axel Scherer and is headquartered in Carlsbad, CA.

Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ.

Sequent Medical, Inc. operates as a medical device company. It develops catheter-based neurovascular technologies. The company was founded by Robert F. Rosenbluth and Brian J. Cox in August 2007 and is headquartered in Aliso Viejo, CA.

Part of Comcast Corp., American Cablesystems Corp. is a company that operates and maintains cable systems.

MergerTech Capital Management LLC (MergerTech Capital) is a venture capital firm founded in 2011 by Nitin Kanna and Karan Kanna. The firm is headquartered in Emeryville, California.

HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut..

Concert Genetics, Inc. operates as a healthcare IT company that focuses on enhancing the genetic test ordering process for the medical community. Its portfolio includes GeneSource, a tool available for physicians and other healthcare professionals to search for, compare and order genetic tests from various laboratories; and GeneConnect, a utilization management solution that leverages the GeneSource database and provides hospitals and sendout laboratories with the tools to lower costs and address workflow inefficiencies associated with the genetic test ordering process. The company was founded by Mark Harris in 2010 and is headquartered in Franklin, TN.

Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA.

Gene Sciences, Inc. operates as a biotechnology company. The company was founded by Fei Yang and is headquartered in San Diego, CA.

Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA.

Gencove, Inc. helps companies, developers and researchers start and manage genomic R&D projects. The company was founded by Tomaz Berisa, Joseph Pickrell, and Kaja Wasik in 2015 and is headquartered in New York, NY.

InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy.

HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY.

Synthetica Bio, Inc. is a company that specializes in generative AI for biopharma. The company is based in Anaheim, CA. The company's solution empowers clinical and commercial teams with actionable knowledge in real time. The company was founded by Simon Arkell, Alexander G. Dickinson. Simon Arkell has been the CEO since incorporation.